Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome
Project Number1U54CA274374-01
Contact PI/Project LeaderGRADY, WILLIAM MALLORY Other PIs
Awardee OrganizationFRED HUTCHINSON CANCER CENTER
Description
Abstract Text
SUMMARY
Colorectal cancer (CRC) affects ~145,000 people/year in the US and is the 3rd most common cause of cancer
related deaths. CRC arises from early lesions that are pre-cancerous; these early lesions are colon adenomas
and serrated sessile lesions (SSL). Colon adenomas account for 80-85% of the CRC precancerous lesions and
progress to CRC via an early adenomaàadvanced adenomaàCRC sequence. In light of the well characterized
clinical natural history of adenomas, we plan to study them as early lesions and to determine the mechanisms
involved in the formation and progression of early precancerous lesions. Notably, only a few early adenomas will
progress to advanced adenomas (AA) and even fewer will progress to CRC. Our group and others have shown
that mutations alone are not sufficient to cause adenoma initiation and/or progression in the majority of cases.
There are likely multiple adenoma nonautonomous mechanisms that cooperate with the DNA alterations in the
adenomas to cause progression, and these mechanisms are likely operative in discrete subsets of affected
individuals. We and others have observed alterations, such as tissue senescence, high cancer driver gene
mutation loads, aberrant DNA methylation patterns, and dysbiotic gut microbiomes, in the normal colon of people
with advanced adenomas and CRC patients. We have termed normal colons with these features “primed colons”
and propose that these features are plausible mechanisms that affect adenoma initiation and progression.
Based on these observations and our prior studies, we hypothesize that early lesion progression requires a suite
of hallmark behaviors and that these behaviors are induced by adenoma autonomous factors (e.g. cancer driver
gene mutations) and adenoma nonautonomous factors from the “primed colon” or adenoma microenvironment.
Our proposed studies will integrate basic and translational cancer research Projects to iteratively examine the
direct causal relationships and interactions of adenomas, the colon “primed” microenvironment, and host-
systemic factors as “co-organizers” of adenoma initiation and/or progression. The Specific Aims are:
Aim 1) To determine the adenoma cell autonomous molecular factors that distinguish nonadvanced adenomas
from advanced adenomas and that regulate nonadvanced adenoma progression. (Projects 1 and 2)
Aim 2) To determine the adenoma nonautonomous factors from the “primed” colon and from the adenoma
microenvironment that associate with advanced human colon adenomas and regulate adenoma progression.
These factors will include the following “primed” colon states: 1. senescence state; 2. cancer driver gene mutation
burden; 3. gut microbiome state; 4. colon methylome, and 5. colon immune activity state. (Projects 1-3)
Aim 3)To determine how adenoma autonomous and nonautonomous factors from the adenoma
microenvironment and the “primed” colon cooperate to drive adenoma formation and progression.(Projcts 1-3)
Public Health Relevance Statement
NARRATIVE
Adenomas are early lesions of colorectal cancer, but only a subset of adenomas progress and become cancer.
In light of the well characterized clinical natural history of adenomas, we plan to study them as early lesions and
to determine the mechanisms involved in the formation and progression of early precancerous lesions. We
hypothesize that adenoma progression requires a suite of hallmark behaviors and that these behaviors are
induced by adenoma autonomous factors (e.g. cancer driver gene mutations) and adenoma nonautonomous
factors from the “primed colon” or adenoma microenvironment. Our proposed studies will integrate basic and
translational cancer research projects to iteratively examine the direct causal relationships and interactions of
adenomas, the colon “primed” microenvironment, and host-systemic factors as “co-organizers” of adenoma
initiation and/or progression.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Aberrant DNA MethylationAffectArchitectureAtlasesBehaviorBiological MarkersBiologyCancer EtiologyCancer Research ProjectCellsCessation of lifeClinicClinicalCollaborationsColonColonic AdenomaColorectal AdenomaColorectal CancerDNA Sequence AlterationData SetEpigenetic ProcessEpithelial CellsFibroblastsGene MutationGoalsHumanImmuneIndividualIndolentLesionLightMalignant NeoplasmsMissionMolecularMutationNatural HistoryPathogenesisPatientsPersonsPositioning AttributeRecording of previous eventsResearch PersonnelRiskScienceSessile LesionTechnologyTestingTissuesTranslational ResearchTranslationsadenomabasecancer geneticscancer typeclinical applicationcohortcolon cancer patientscolorectal cancer preventioncolorectal cancer progressiondeep sequencingdysbiosisexperiencegut microbiomehuman diseaseinnovationmethylation patternmethylomemicrobiomemouse modelmultiple omicsmutantnovelpremalignantsenescencetranslational cancer researchtumor
No Sub Projects information available for 1U54CA274374-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U54CA274374-01
Patents
No Patents information available for 1U54CA274374-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U54CA274374-01
Clinical Studies
No Clinical Studies information available for 1U54CA274374-01
News and More
Related News Releases
No news release information available for 1U54CA274374-01
History
No Historical information available for 1U54CA274374-01
Similar Projects
No Similar Projects information available for 1U54CA274374-01